---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-048260"
form_type: "8-K"
ticker: "UFPT"
cik: "0000914156"
company_name: "UFP TECHNOLOGIES INC"
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T01:02:15.017768+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# UFP Technologies Q3 EPS flat at $2.11; sales up 6.5% but organic sales flat due to labor issue

## Summary
- Q3 net income $16.4M ($2.11 diluted EPS), flat YoY; adjusted EPS $2.39.
- Sales $154.6M (+6.5% YoY); MedTech up 7.3% to $142.4M; non-medical down 2.7%.
- Gross margin fell to 27.7% from 28.6% due to ~$3M incremental labor cost at Illinois AJR facility; absent that, would have been 29.6%.
- Organic sales flat; over $8M in orders unfulfilled due to labor eligibility review at AJR; Q4 impact expected to be significantly less.
- Two new robotic surgery programs on track for commercial production by year-end; CEO expects significant 2026+ revenue.

## SEC filing metadata
- accession: 0001628280-25-048260
- form_type: 8-K
- ticker: UFPT
- cik: 0000914156
- company_name: UFP TECHNOLOGIES INC
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914156/000162828025048260/0001628280-25-048260-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914156/000162828025048260/ufpt-20251103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-048260
- JSON: https://secwatch.observer/filing/0001628280-25-048260.json
- Plain text: https://secwatch.observer/filing/0001628280-25-048260.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
